Major Depressive Disorder Mdd clinical trials

Explore recruiting major depressive disorder mdd clinical trials.

Recruiting major depressive disorder mdd studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Major Depressive Disorder Mdd trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

NBI-1065845-MDD3024: A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NBI-1065845 as Adjunctive Treatment in Subjects with Major Depressive Disorder (MDD)

Poland, Croatia, Czechia

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized, Double-Blind, Placebo-controlled Multicenter Study to Assess the Efficacy and Safety of Milsaperidone as Adjunctive Therapy in the Treatment of Patients with Major Depressive Disorder

Poland, Czechia, Bulgaria

Therapeutic confirmatory (Phase III) EU CTIS Study details

Reward-specific changes of cerebral dopamine synthesis in healthy volunteers and depressed patients

Austria

Therapeutic use (Phase IV) EU CTIS Study details

The additive effect of ketamine in combination with electroconvulsive stimulation (ECS) in major depressive disorder (MDD): a translational study

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

TMSxDCS: Pharmacologically augmenting transcranial magnetic stimulation for depression

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

INSTA-MD: INflammation-based Stratification for immune-Targeted Augmentation in Major Depressive disorder

Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

Major Depressive Disorder Mdd trials by city

Major Depressive Disorder Mdd in Toronto Major Depressive Disorder Mdd in Vancouver Major Depressive Disorder Mdd in Montreal Major Depressive Disorder Mdd in Calgary Major Depressive Disorder Mdd in Edmonton Major Depressive Disorder Mdd in Ottawa Major Depressive Disorder Mdd in Winnipeg Major Depressive Disorder Mdd in Quebec City Major Depressive Disorder Mdd in Hamilton Major Depressive Disorder Mdd in Kitchener Major Depressive Disorder Mdd in London Major Depressive Disorder Mdd in Halifax Major Depressive Disorder Mdd in New York Major Depressive Disorder Mdd in Los Angeles Major Depressive Disorder Mdd in Chicago Major Depressive Disorder Mdd in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease